Those studies were conducted in a cell line (U937) representing a different type of AML, and probably carrying additional oncogenic mutations, suggesting that RUNX1-ETO cannot reprogram one leukemic cell type into another. The gene discussed is RUNX1; the disease is acute myeloid leukemia.